Publication | Closed Access

Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9

Tissue EngineeringSclerostinEngineeringPhysiologyTissue InhibitorEndothelial DysfunctionVascular BiologyBiomedical EngineeringSuperoxide DismutaseMatrix BiologyEndometriotic ImplantsMedicineOsteoporosisExtracellular Matrix